{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T15:35:22Z","timestamp":1767713722589},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","worldneurosurgery.org","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["World Neurosurgery"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.wneu.2018.04.070","type":"journal-article","created":{"date-parts":[[2018,4,17]],"date-time":"2018-04-17T02:39:06Z","timestamp":1523932746000},"page":"e464-e471","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Clinical Parameters to Distinguish Silent Corticotroph Adenomas from Other Nonfunctioning Pituitary Adenomas"],"prefix":"10.1016","volume":"115","author":[{"given":"Daham","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheol Ryong","family":"Ku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Se Hee","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ju Hyung","family":"Moon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eui Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sun Ho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun Jig","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.wneu.2018.04.070_bib1","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.humpath.2004.04.016","article-title":"Silent corticotroph adenomas: further clinical and pathological observations","volume":"35","author":"Lopez","year":"2004","journal-title":"Hum Pathol"},{"key":"10.1016\/j.wneu.2018.04.070_bib2","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/j.1365-2265.2009.03673.x","article-title":"Silent corticotroph adenomas have unique recurrence characteristics compared with other nonfunctioning pituitary adenomas","volume":"72","author":"Cho","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.wneu.2018.04.070_bib3","first-page":"723","article-title":"Clinically silent corticotroph tumors of the pituitary gland","volume":"47","author":"Scheithauer","year":"2000","journal-title":"Neurosurgery"},{"key":"10.1016\/j.wneu.2018.04.070_bib4","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s11102-014-0624-3","article-title":"Silent corticotroph adenomas","volume":"18","author":"Cooper","year":"2015","journal-title":"Pituitary"},{"key":"10.1016\/j.wneu.2018.04.070_bib5","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1227\/01.neu.0000429858.96652.1e","article-title":"A\u00a0comprehensive long-term retrospective analysis of silent corticotrophic adenomas vs hormone-negative adenomas","volume":"73","author":"Jahangiri","year":"2013","journal-title":"Neurosurgery"},{"key":"10.1016\/j.wneu.2018.04.070_bib6","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1227\/NEU.0b013e318257c1f0","article-title":"Silent corticotroph adenomas: Emory University cohort and comparison with ACTH-negative nonfunctioning pituitary adenomas","volume":"71","author":"Ioachimescu","year":"2012","journal-title":"Neurosurgery"},{"key":"10.1016\/j.wneu.2018.04.070_bib7","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s12672-010-0014-x","article-title":"Silent corticogonadotroph adenomas: clinical and cellular characteristics and long-term outcomes","volume":"1","author":"Cooper","year":"2010","journal-title":"Horm Cancer"},{"key":"10.1016\/j.wneu.2018.04.070_bib8","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1080\/02688690500081230","article-title":"A\u00a0spectrum of behaviour in silent corticotroph pituitary adenomas","volume":"19","author":"Baldeweg","year":"2005","journal-title":"Br J Neurosurg"},{"key":"10.1016\/j.wneu.2018.04.070_bib9","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1210\/jc.2010-1048","article-title":"Pituitary incidentaloma: an endocrine society clinical practice guideline","volume":"96","author":"Freda","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.wneu.2018.04.070_bib10","doi-asserted-by":"crossref","first-page":"E533","DOI":"10.1227\/NEU.0000000000001389","article-title":"Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline on Primary Management of Patients with Nonfunctioning Pituitary Adenomas","volume":"79","author":"Lucas","year":"2016","journal-title":"Neurosurgery"},{"key":"10.1016\/j.wneu.2018.04.070_bib11","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1111\/cen.13146","article-title":"Prevalence of clinically silent corticotroph macroadenomas","volume":"85","author":"Guttenberg","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.wneu.2018.04.070_bib12","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3803\/EnM.2015.30.1.7","article-title":"Clinical guidelines for the diagnosis and treatment of Cushing's disease in Korea","volume":"30","author":"Hur","year":"2015","journal-title":"Endocrinol Metab (Seoul)"},{"key":"10.1016\/j.wneu.2018.04.070_bib13","first-page":"ons192","article-title":"Surgical and endocrinological outcomes in the treatment of growth hormone-secreting pituitary adenomas according to the shift of surgical paradigm","volume":"71","author":"Ku","year":"2012","journal-title":"Neurosurgery"},{"key":"10.1016\/j.wneu.2018.04.070_bib14","doi-asserted-by":"crossref","first-page":"942","DOI":"10.3171\/2011.12.JNS11875","article-title":"Coexistence of intracranial aneurysm in 800 patients with surgically confirmed pituitary adenoma","volume":"116","author":"Oh","year":"2012","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2018.04.070_bib15","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1530\/EJE-14-0304","article-title":"Clinical predictors of GH deficiency in surgically cured acromegalic patients","volume":"171","author":"Ku","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.wneu.2018.04.070_bib16","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3803\/EnM.2010.25.4.310","article-title":"Correlation between pituitary insufficiency and magnetic resonance imaging finding in non-functioning pituitary adenomas","volume":"25","author":"Kim","year":"2010","journal-title":"Endocrinol Metab"},{"key":"10.1016\/j.wneu.2018.04.070_bib17","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3803\/EnM.2015.30.4.443","article-title":"Diagnosis and treatment of hypopituitarism","volume":"30","author":"Kim","year":"2015","journal-title":"Endocrinol Metab (Seoul)"},{"key":"10.1016\/j.wneu.2018.04.070_bib18","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12902-015-0055-9","article-title":"Low immediate postoperative serum-cortisol nadir predicts the short-term, but not long-term, remission after pituitary surgery for Cushing's disease","volume":"15","author":"Ramm-Pettersen","year":"2015","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.wneu.2018.04.070_bib19","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11102-006-9276-2","article-title":"Disorders of water metabolism following transsphenoidal pituitary surgery: a single institution's experience","volume":"9","author":"Adams","year":"2006","journal-title":"Pituitary"},{"key":"10.1016\/j.wneu.2018.04.070_bib20","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-17-0796","article-title":"European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas","volume":"178","author":"Raverot","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.wneu.2018.04.070_bib21","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0889-8529(18)30412-2","article-title":"Diagnostic evaluation of Cushing's syndrome","volume":"17","author":"Carpenter","year":"1988","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.wneu.2018.04.070_bib22","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3803\/EnM.2015.30.3.297","article-title":"Limited diagnostic utility of plasma adrenocorticotropic hormone for differentiation between adrenal Cushing syndrome and Cushing disease","volume":"30","author":"Hong","year":"2015","journal-title":"Endocrinol Metab (Seoul)"},{"key":"10.1016\/j.wneu.2018.04.070_bib23","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1227\/01.NEU.0000290906.53685.79","article-title":"A\u00a0study of the correlation between morphological findings and biological activities in clinically nonfunctioning pituitary adenomas","volume":"61","author":"Yamada","year":"2007","journal-title":"Neurosurgery"},{"key":"10.1016\/j.wneu.2018.04.070_bib24","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1530\/EJE-07-0428","article-title":"Differential gene expression in ACTH -secreting and non-functioning pituitary tumors","volume":"157","author":"Tateno","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.wneu.2018.04.070_bib25","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.1210\/jc.2003-031531","article-title":"Prepubertal Cushing's disease is more common in males, but there is no increase in severity at diagnosis","volume":"89","author":"Storr","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.wneu.2018.04.070_bib26","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1046\/j.1365-2265.2003.01674.x","article-title":"Non-functioning pituitary adenomas with positive immunoreactivity for ACTH behave more aggressively than ACTH immunonegative tumours but do not recur more frequently","volume":"58","author":"Bradley","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.wneu.2018.04.070_bib27","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1227\/01.NEU.0000088660.16904.F7","article-title":"Clinical characteristics of silent corticotrophic adenomas and creation of an internet-accessible database to facilitate their multi-institutional study","volume":"53","author":"Webb","year":"2003","journal-title":"Neurosurgery"},{"key":"10.1016\/j.wneu.2018.04.070_bib28","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1227\/01.NEU.0000223437.51435.6E","article-title":"Pathobiology of pituitary adenomas and carcinomas","volume":"59","author":"Scheithauer","year":"2006","journal-title":"Neurosurgery"},{"key":"10.1016\/j.wneu.2018.04.070_bib29","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1007\/s00701-012-1378-1","article-title":"Clinical features of silent corticotroph adenomas","volume":"154","author":"Alahmadi","year":"2012","journal-title":"Acta Neurochir (Wien)"},{"key":"10.1016\/j.wneu.2018.04.070_bib30","doi-asserted-by":"crossref","first-page":"538D","DOI":"10.1136\/jnnp.68.4.538d","article-title":"Russell and Rubinstein's pathology of tumors of the nervous system. Sixth edition","volume":"68","author":"Esiri","year":"2000","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.wneu.2018.04.070_bib31","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1677\/joe.0.0400015","article-title":"A\u00a0fundamental defect of adrenocortical control in Cushing's disease","volume":"40","author":"James","year":"1968","journal-title":"J\u00a0Endocrinol"},{"key":"10.1016\/j.wneu.2018.04.070_bib32","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1210\/jcem-44-2-361","article-title":"Plasma ACTH and cortisol responses to TRF, vasopressin or hypoglycemia in Cushing's disease and nelson's syndrome","volume":"44","author":"Krieger","year":"1977","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.wneu.2018.04.070_bib33","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s12020-016-0863-3","article-title":"Thyrotropin-secreting pituitary adenomas: epidemiology, diagnosis, and management","volume":"52","author":"Amlashi","year":"2016","journal-title":"Endocrine"},{"key":"10.1016\/j.wneu.2018.04.070_bib34","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1210\/jcem.84.2.5505","article-title":"Thyrotropin-secreting pituitary tumors: diagnostic criteria, thyroid hormone sensitivity, and treatment outcome in 25 patients followed at the National Institutes of Health","volume":"84","author":"Brucker-Davis","year":"1999","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.wneu.2018.04.070_bib35","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1210\/jcem-53-1-165","article-title":"Anterior pituitary function after transsphenoidal selective adenomectomy in patients with Cushing's disease","volume":"53","author":"Kuwayama","year":"1981","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.wneu.2018.04.070_bib36","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1507\/endocrj1954.38.559","article-title":"Anterior pituitary function in Cushing's syndrome: study of 36 patients","volume":"38","author":"Cuerda","year":"1991","journal-title":"Endocrinol Jpn"},{"key":"10.1016\/j.wneu.2018.04.070_bib37","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1210\/jcem-71-3-712","article-title":"Diminished adrenocorticotropin response to insulin-induced hypoglycemia in nondepressed, actively drinking male alcoholics","volume":"71","author":"Berman","year":"1990","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.wneu.2018.04.070_bib38","doi-asserted-by":"crossref","first-page":"4406","DOI":"10.1210\/jc.2009-0471","article-title":"Predicting recurrence of nonfunctioning pituitary adenomas","volume":"94","author":"Noh","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.wneu.2018.04.070_bib39","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.wneu.2016.09.092","article-title":"Aggressive pituitary adenomas: the dark side of the moon","volume":"97","author":"Priola","year":"2017","journal-title":"World Neurosurg"},{"key":"10.1016\/j.wneu.2018.04.070_bib40","first-page":"610","article-title":"Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings","volume":"33","author":"Knosp","year":"1993","journal-title":"Neurosurgery"},{"key":"10.1016\/j.wneu.2018.04.070_bib41","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.wneu.2016.08.088","article-title":"Cavernous sinus invasion in pituitary adenomas: systematic review and pooled data meta-analysis of radiologic criteria and comparison of endoscopic and microscopic surgery","volume":"96","author":"Dhandapani","year":"2016","journal-title":"World Neurosurg"},{"key":"10.1016\/j.wneu.2018.04.070_bib42","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1210\/jc.2008-0139","article-title":"Accuracy of diagnostic tests for Cushing's syndrome: a systematic review and metaanalyses","volume":"93","author":"Elamin","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.wneu.2018.04.070_bib43","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1507\/endocrj.EJ14-0120","article-title":"Pathophysiology and treatment of subclinical Cushing's disease and pituitary silent corticotroph adenomas [review]","volume":"61","author":"Kageyama","year":"2014","journal-title":"Endocr J"},{"key":"10.1016\/j.wneu.2018.04.070_bib44","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/BF03344133","article-title":"Endogenous subclinical hypercortisolism: diagnostic uncertainties and clinical implications","volume":"29","author":"Tsagarakis","year":"2006","journal-title":"J\u00a0Endocrinol Invest"}],"container-title":["World Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875018307885?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875018307885?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,15]],"date-time":"2019-10-15T21:53:36Z","timestamp":1571176416000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878875018307885"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":44,"alternative-id":["S1878875018307885"],"URL":"https:\/\/doi.org\/10.1016\/j.wneu.2018.04.070","relation":{},"ISSN":["1878-8750"],"issn-type":[{"value":"1878-8750","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Parameters to Distinguish Silent Corticotroph Adenomas from Other Nonfunctioning Pituitary Adenomas","name":"articletitle","label":"Article Title"},{"value":"World Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.wneu.2018.04.070","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}